Novo's commercial strategy head hits the exit, prompting a slew of executive team shakeups
Camilla Sylvest is stepping down from her role as executive vice president, commercial strategy and corporate affairs after nearly three decades of service to the Danish drugmaker.
Camilla Sylvest is stepping down from her role as executive vice president, commercial strategy and corporate affairs after nearly three decades of service to the Danish drugmaker.
